Apitolisib (GDC-0980), a novel dual PI3K/mTOR inhibitor of mTORC1/2 and PI3K class I tested in solid tumors, including those of the brain, inhibits growth and induces apoptosis in human glioblastoma cells. This evidence concerns the gene MTOR and glioblastoma.